Foot Drop Treatment Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 9.50 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Foot Drop Treatment Market Analysis
The Foot Drop Treatment Market is expected to register a CAGR of 9.5% during the forecast period, 2022-2027.
COVID-19 has uplifted the market studied in a way that ensures a long-term reliance of consumers on bone and joint health supplements. As hospitals are overwhelmed by COVID-19 patients, elective surgeries were canceled or indefinitely delayed. This, in turn, has led consumers toward immediate alternatives such as medications or supplements to ensure proper health, increasing the demand for associated industries, including bone and joint health ingredients. According to the National Osteoporosis Foundation (NOF) survey, osteoporosis patients continued appointments with doctors through various modes in COVID-19: 33% used telephone consultations, 21% used video consultations, 26% used face-to-face appointments, 18% used urgent 'in-person visits, and 3% used other modalities such as instant messaging or attendance for parenteral therapies. As a result, during major lockdowns, the market for foot drop treatment remained mostly unaffected.
A musculoskeletal disorder leads to restricted mobility and it is one of the major contributors worldwide to disability. Musculoskeletal disorder is one of the major causes of foot drop. According to the World Health Organization (WHO), facts published in July 2022, approximately 1.71 billion people have musculoskeletal conditions worldwide. Also, musculoskeletal conditions are the leading contributor to disability worldwide. As per the same source, high-income countries are the most affected in terms of several people - 441 million - followed by countries in the WHO Western Pacific Region with 427 million and the South-East Asia Region with 369 million. Musculoskeletal conditions are also the biggest contributor to years lived with disability (YLDs) worldwide with approximately 149 million YLDs, accounting for 17% of all YLDs worldwide. Thus the increase in musculoskeletal disorders worldwide requires the treatment of these disorders. Thus, the market is expected to see a surge over the forecast period.
Moreover, Heliyon published a study in 2020 in which a pedi-anklebot robot was evaluated for foot drop treatment. Ankle motor performance was measured, and great accuracy in ankle trajectories was observed. Hence, the new emerging treatment options are expected to drive the global foot drop treatment market in the forecast period.
However, the high cost of functional electrical stimulators is likely to impede the market growth over the forecast period.
Foot Drop Treatment Market Trends
This section covers the major market trends shaping the Foot Drop Treatment Market according to our research experts:
Functional Electrical Stimulator Segment is Expected to Show a Significant Growth Rate in the Foot Drop Treatment Market
Functional Electrical Stimulator (FES) uses electrical pulses to stimulate the tissues that help in improving motion, increasing blood circulation, and preventing muscular atrophy.
Furthermore, the rising company activities in launching advanced products are expected to increase the demand for the treatment of foot drop, thereby boosting the market growth. For instance, in March 2022, announced its first product offering, the lightweight leg-worn Cionic Neural Sleeve, was granted Food and Drug Administration clearance for 'functional electrical stimulation to assist in gait for people with foot drop and leg muscle weakness.
Furthermore, the growing burden of brain and spinal disorders is expected to influence positively on the FES segment market. According to the study 'Prevalence of Spine Degeneration Diagnosis by Type, Age, Gender, and Obesity Using Medicare Data' published in the Scientific Report in March 2021, Age was a factor in the prevalence of diagnosed spinal degenerative disease, which was 27.3 percent overall. Additionally, according to an article published by the National Center for Biotechnology Information, in 2021, titled 'Spinal Cord Injuries', stated that in the United States, there are approximately 17,000 new cases of spinal cord injuries (SCI) each year. Thus, the increasing prevalence of spinal degeneration and spinal cord injury is anticipated to boost the market growth.
Thus, all aforementioned factors expected to boost the segment growth over the forecast period.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America is expected to hold a major market share in the global foot drop treatment market due to the high prevalence of stroke, increasing spinal cord and brain disorders, and an increasing number of product approvals. Foot drop can arise due to a stroke.
According to an article published by the National Center for Biotechnology Information, in 2021, titled 'Spinal Cord Injuries', stated that in the United States, there are approximately 17,000 new cases of spinal cord injuries (SCI) each year. Moreover, according to the data published by the American Association of Neurological Surgeons, in the June 2021 report, it has been observed that more than 450,000 people in the United States are living with a spinal cord injury (SCI). Additionally, according to an article published by the National Center for Biotechnology Information, in March 2021, titled 'Prevalence of Spine Degeneration Diagnosis by Type, Age, Gender, and Obesity Using Medicare Data,' the prevalence rate of diagnosed spinal degenerative disease was found to be 27.3%. Thus, growing the prevalence of spinal cord disease is expected to drive the growth of the market over the forecast period.
Moreover, according to the statistics published by the Centers for Disease Control and Prevention (CDC) in April 2022, more than 795,000 Americans have strokes. Of this 610,000 are found to be new cases each year. Statistics also showed that Stroke is one of the leading causes of death in the United States and every 40 seconds, someone from the United States has a stroke. This huge patient base is expected to increase the demand for foot drop treatment in the region over the forecast period.
Hence, due to the aforementioned factors, the market is expected to see a surge over the forecast period.
Foot Drop Treatment Industry Overview
The foot drop treatment market is fragmented and competitive and consists of a number of major players. Companies are constantly showing their presence in the market through product launches, collaborations, mergers & acquisitions. Some of the companies which are currently dominating the market are Ottobock, Bioness Inc., Axio Bionics, Accelerated Care Plus Corporation, Saebo, Inc., Boston Orthotics & Prosthetics, Turbomed Orthotics, Ossur, Thrive Orthopedics, and Allard.
Foot Drop Treatment Market Leaders
-
Bioness Inc.
-
Saebo Inc.
-
Boston Orthotics & Prosthetics
-
Ottobock
-
Ossur
*Disclaimer: Major Players sorted in no particular order
Foot Drop Treatment Market News
- As per the news published in August 2022, a Velcro sleeve fastened around the leg has been designed with electrodes that help stimulate the muscles of those who experience difficulty getting around due to nervous system conditions. This device will be ready for delivery to those who have experienced a stroke, or have multiple sclerosis or cerebral palsy, in 2023.
- In March 2022, The United States Food and Drug Administration (USFDA) granted approval for Cionic's lightweight leg-worn Neural Sleeve. Neural Sleeve is designed for analyzing, predicting, and augmenting the movements of a person.
Foot Drop Treatment Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Burden of Chronic Diseases
4.2.2 Advancements in Products
4.3 Market Restraints
4.3.1 High Cost of Functional Electrical Stimulators
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Product Type
5.1.1 Functional Electrical Stimulator
5.1.2 Braces/Splints
5.2 By Application
5.2.1 Neuropathy
5.2.2 Muscle Disorders
5.2.3 Brain & Spinal Disorders
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Accelerated Care Plus Corporation
6.1.2 Allard
6.1.3 Axio Bionics
6.1.4 Bioness Inc.
6.1.5 Boston Orthotics & Prosthetics
6.1.6 Ossur
6.1.7 Ottobock
6.1.8 Saebo, Inc.
6.1.9 Thrive Orthopedics
6.1.10 Turbomed Orthotics
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Foot Drop Treatment Industry Segmentation
Foot drop refers to improper gait functionality that results in difficulty in lifting the front part of the foot. The market is segmented By Product Type (Electrical Stimulator, Braces/Splints), By Application (Neuropathy, Muscle Disorders, and Brain & Spinal Disorders), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
| By Product Type | |
| Functional Electrical Stimulator | |
| Braces/Splints |
| By Application | |
| Neuropathy | |
| Muscle Disorders | |
| Brain & Spinal Disorders |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Foot Drop Treatment Market Research FAQs
What is the current Global Foot Drop Treatment Market size?
The Global Foot Drop Treatment Market is projected to register a CAGR of 9.5% during the forecast period (2024-2029)
Who are the key players in Global Foot Drop Treatment Market?
Bioness Inc. , Saebo Inc. , Boston Orthotics & Prosthetics , Ottobock and Ossur are the major companies operating in the Global Foot Drop Treatment Market.
Which is the fastest growing region in Global Foot Drop Treatment Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Foot Drop Treatment Market?
In 2024, the North America accounts for the largest market share in Global Foot Drop Treatment Market.
What years does this Global Foot Drop Treatment Market cover?
The report covers the Global Foot Drop Treatment Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Foot Drop Treatment Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Vascular Patches Industry Report
Statistics for the 2024 Vascular Patches market share, size and revenue growth rate, created by Mordor Intelligenceā¢ Industry Reports. Vascular Patches analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
Foot Drop Treatment Market Report Snapshots
